The concept that health system capacity might induce demand goes back half a century to Roemer's law. 1 Empirical studies in the 1970s suggested that physician supply had an independent impact on utilization of services. 2, 3 More recent research from the Dartmouth Atlas among Medicare beneficiaries has concluded that higher capacity creates more intensive utilization and higher costs without measurable benefit in outcomes or patient satisfaction. [4] [5] [6] However, other literature using state-level analysis has suggested a health benefit of more physicians and greater medical spending. 7, 8 Several authors have also questioned the analytic methods of the Dartmouth Atlas Project. 9, 10 In addition, other research has suggested that greater physician supply does not increase utilization in the absence of other supply-side factors, such as a high density of hospital beds 11 or a high proportion of international medical graduates (IMGs). 12 Moreover, the extent to which utilization patterns across diverse populations can be understood based on Medicare beneficiaries is not known. There are significant differences in commercially insured patients and the hospital markets that serve them. 13 Meanwhile, there is a large expansion of medical school enrollment currently under way, directed at greatly increasing the supply of physicians.
14 Given the inconclusive nature of the evidence supporting physician-induced demand, a greater understanding of the factors which produce discretionary and unnecessary utilization is essential. Moreover, much of the evidence in this area has analyzed the care of elderly Medicare beneficiaries. Since health policy initiatives must be based on robust evidence that incorporates diverse types of patients, data incorporating other populations are critical.
The use of esophagogastroduodenoscopy (EGD) in patients with lower gastrointestinal bleeding (LGIB) is a natural place to expect the effects of physician-induced demand. Despite guidelines on the appropriate indications for colonoscopy and EGD, [15] [16] [17] [18] procedures performed without an appropriate clinical indication (i.e., inappropriate procedures) are common, despite the presence of guidelines published by the American Society for Gastrointestinal Endoscopy. 19 One study concluded that, among colonoscopies, 25% in outpatients and 16% in inpatients were inappropriate. 16 Surveillance colonoscopies are performed in excess of those recommended by guidelines. 20 Among hospitalized patients, 17% to 77% of EGDs are inappropriate. 21, 22 In support of this, EGDs are more likely to be normal when performed for an inappropriate indication. 18, 21 We studied patients hospitalized with LGIB to understand the impact of relevant clinical histories, gastroenterologist density, and local practice patterns on colonoscopies and EGDs in a commercially insured population. 
Conclusions
Among patients hospitalized with LGIB, large variation in gastroenterologist density did not predict EGD, but relevant clinical history did, with association strengths commensurate with risk for upper gastrointestinal bleeding. In the scenario studied, no evidence was found that specialty physician supply increases will result in more discretionary care within commercially insured populations.
Method

Data sources and study population
Utilization and demographic data were obtained from the 2004-2009 Thomson Reuters MarketScan databases, which have been previously described. 13, 23 These databases contain deidentified linked health insurance claims from over 80 million enrollees from all 50 U.S. states across approximately 100 commercial payers and large, self-insured corporations. Using inpatient claims data, we identified patients hospitalized with LGIB (index hospitalization) based on a published algorithm. 24 This algorithm uses a set of International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes 25 to identify potential LGIB patients and excludes patients likely to have upper gastrointestinal bleeding or chronic blood loss using a specified set of discharge diagnostic and procedure codes. Using a unique patient identifier, we linked to each patient's outpatient utilization data contained in the Outpatient Services Table, which is part of the MarketScan database inventory. 23 We excluded patients who were not continuously enrolled for 12 months before and 6 months after the index hospitalization. For patients with multiple admissions meeting the definition of LGIB, we used the first admission. We then used Current Procedural Terminology codes (see Supplemental Digital Appendix 1 at http://links.lww.com/ACADMED/A409 for codes) to identify patients who had a colonoscopy, EGD, or sigmoidoscopy during their index hospitalization or within 6 months of discharge. A composite measure indicates patients who had each procedure in either setting.
The 29 comorbidity indicator variables (CIVs) were coded by mapping ICD-9-CM codes according to the Elixhauser Comorbidity Software. 26 We included diagnostic codes if they appeared at least once in the Outpatient Services Table or  the Inpatient Admissions Tables during  the year before the index hospitalization. Using the same codes specified above, we identified outpatient claims for LGIB prior to the index hospitalization. We defined patients with a prior history of upper gastrointestinal disease, using three alternative definitions: the codes used in the Elixhauser Comorbidity Software, 26 which include peptic ulcer disease (PUD), generally excluding diagnoses which involve bleeding; a history of PUD with or without bleeding, 27 The 306 hospital referral regions (HRRs) are geographic units developed by the Dartmouth Atlas Project, which are commonly used to examine geographic variations in health care utilization. 4, 5, 30 Thomson Reuters provided a linkage file containing the HRR for each patient enrolled in each year. We linked patient utilization data with HRRlevel measures from the Dartmouth Atlas-gastroenterologist density (GID) and hospital care intensity (HCI) index. 31 The HCI index is a measure of utilization intensity computed as the age-sex-race-illness standardized ratio of days spent in the hospital and number of inpatient physician encounters, which we included in the analysis because it is a well-validated measure of the impact that practice patterns have on utilization. 32 We also used the Federal Information Processing Standard code to link to the Area Resource File, from which we obtained indicators for race and education level based on county of residence. 33 
Outcome measures and statistical analysis
Patient characteristics were compared by a two-sample t test for age, and chisquare test for categorical variables. The primary outcome was the association of GID quartile, HCI index quartile, and prior history of upper gastrointestinal disease with the composite EGD measure. The associations of composite EGD with the more restrictive definitions of upper gastrointestinal disease (PUD only) as well as composite colonoscopy with GID and HCI index were secondary outcomes. The independent variables for each logistic regression were either patient level (age by quintile, gender, 28 of the CIVs [replacing nonbleeding PUD with a history of any upper gastrointestinal disease or all PUD]), county level (percent white, black, and Asian by quartile; percent low, medium, and high education by quartile), or HRR level (GID quartile and HCI index quartile). For all categorized continuous variables, the lowest quantile was consistently specified as the reference group. We used the Stata variance-covariance estimator that adjusted the standard errors for intragroup clustering at the HRR level.
Statistical analyses were performed with Stata 11.2 statistical software (StataCorp, College Station, Texas) and SAS statistical software, version 9.2 (SAS Institute Inc., Cary, North Carolina). This study was approved by the University of Chicago Medical Center institutional review board.
Results
We identified 34,344 continuously enrolled patients admitted with an LGIB. Table 1 shows the characteristics of the study subjects (mean age 49.9), of whom 53.6% were female. The most common comorbidities identified were hypertension (23.7%) and diabetes mellitus (10.8%). Compared with those who did not, patients who had a colonoscopy or an EGD were older (P < .0001 for both) than those who did not. Patients with solid tumor malignancies or metastatic cancer were less likely to have a colonoscopy (P < .01) or an EGD (P < .01). Patients who had a coagulation disorder were less likely to have a colonoscopy (P < .01), and those with liver disease were more likely to have an EGD (P < .01). Table 2 shows the proportion of study subjects who had the study procedures during the index hospitalization and within the subsequent six months. The composite proportions show that colonoscopy, EGD, and sigmoidoscopy were performed in 43.1%, 21.3%, and 6.3% of patients, respectively, either during the index hospitalization or within the subsequent six months.
A history of upper gastrointestinal disease was identified in a minority of patients: nonbleeding PUD 0.2%, PUD with or without bleeding 3.2%, and any upper gastrointestinal disease 27.5%. Also, 33.4% of patients had a prior outpatient claim suggesting LGIB. Figure 1 shows the proportion of patients who had each procedure according to quartile of GID (overall mean 3.36, range 0.92-6.93 gastroenterologists per 100,000 population, lowest to highest quartile means: 2.28, 3.00, 3.42, and 4.75). Figure 2 shows the proportion of patients who had an EGD, relative to 21.3% in the total sample, according to history of relevant disease: 32% of those with any upper gastrointestinal disease, 40.3% of those with a nonbleeding ulcer, and 55.3% of those with a bleeding or nonbleeding ulcer. 19 ; 95% CI 1.14-1.25). Despite these findings, the explanatory value of our model is far from complete, suggesting that there are many unmeasured factors that may influence the likelihood of patients to receive endoscopy.
Discussion
There is a large body of evidence consistent with the theory that health system capacity induces utilization. Higher hospital bed supply is associated with more frequent use of the inpatient setting for discretionary hospitalizations, as well as longer length of stay (LOS). 34 Greater supply of physicians has been associated with a higher likelihood of surgery 3 and physician-initiated ambulatory visits. 35 There is also evidence suggesting a synergistic effect of physician and bed supply in escalating utilization. 6 One study suggested that capacity was a more important driver of referral than clinical factors. 36 Some evidence suggests that, in the setting of patient shortages, procedures per physician, physicianinitiated visits, and per patient income increase. 35 There is a complex set of factors determining utilization, including educational and cultural factors, 37 for which workforce planning must account.
However, there is still considerable debate regarding the role that these supply-side factors play in discretionary utilization. A recent study showed that higher surgical rates among decedents was associated with more hospital beds and greater regional per capita end-of-life expenditure patterns, but not the supply of surgeons. 11 Another demonstrated that invasive procedures were not more common in physicianowned hospitals, concluding that only noninvasive services exhibit discretionary variation. 38 This contradicts work suggesting that greater density of surgeons creates demand for operations. 2, 3, 39 Other research has shown that a higher proportion of female or IMG physicians increases costs, but greater density of surgical or medical specialists does not. 12 Despite the continued debate over these issues, the Association of American Medical Colleges spearheaded a remarkable attempt to increase physician supply by 30% without assurances that this increase will solve the primary care crisis.
14 Moreover, the Center for Medicare and Medicaid Services has been hesitant to fund more graduate medical education positions in the absence of evidence that such funding would provide value to the health care system. Given this, the implications of expanding medical school enrollment in the United States are unclear. Especially given that historically, such increases have resulted a For all subgroups (female, subjects with each comorbidity), the proportion who had a colonoscopy and EGD was significantly different than the total sample (P < .01) except for these (not significant). in large expansions in specialty physician supply, this hesitation reflects the interest of the public, for whom the greatest value may be in better access to primary care.
We investigated physician-induced demand in a commercially insured population. An EGD is recommended as the initial examination among adult patients with LGIB if nasogastric aspiration (NGA) shows evidence of an upper GIB or if there is hemodynamic compromise. 40 An EGD is also indicated if a colonoscopy does not identify the source of bleeding. Despite this, among 1,112 patients hospitalized with LGIB in a previous study, all underwent colonoscopy and 62% also underwent EGD. 41 Since that study did not report the results of NGA or physiologic indicators, the indications for the EGDs cannot be known with certainty. However, in that study, the most common chief complaints at presentation were hematochezia (55.5%), maroon stool (16.7%), and melena (11.0%), only the last of which is a potential indication for an EGD before a colonoscopy in the absence of hemodynamic compromise. 42 Another study showed that hypotension was present in only 3.8% of patients hospitalized with LGIB. 43 It is therefore likely that a substantial proportion of the 690 EGDs performed in the aforementioned study were either unnecessary or discretionary, consistent with other literature. 21, 22 Based on the body of evidence suggesting that many endoscopic procedures are inappropriate, we chose EGD among patients hospitalized with LGIB to study the role of specialist supply, local practice patterns, and clinical histories in discretionary utilization. An important strength of our data source is linked data on outpatient utilization, avoiding bias that may occur with samples restricted to inpatient care due to geographic differences in LOS or patterns of care among hospitalized patients. Restricting our sample to continuously enrolled patients ensured capture of the vast majority of utilization.
Our findings suggest that medically appropriate clinical history predicts discretionary utilization within this study sample to a greater extent than system capacity or practice patterns. Neither physician supply (as measured by GID) nor intensity of local practice patterns (as measured by the HCI index) was associated with performance of EGD, accounting for history of upper gastrointestinal disease. Our findings are consistent with other studies suggesting that physician supply alone does not induce discretionary utilization. 11, 12 In addition, our analysis suggests that physicians withhold specialty referral or gastrointestinal endoscopies among patients with metastatic cancer and risk factors for bleeding. Our findings also show that physicians are appropriately influenced by a history of liver disease in the decision to perform EGD among patients with LGIB since concomitant liver disease makes hematochezia more likely to arise from an upper gastrointestinal source. 44 Moreover, prior bleeding PUD is more strongly associated with EGD than is a history of nonbleeding PUD, further evidence of appropriate clinical decisions concordant with guidelines.
This study has limitations, mostly related to the use of administrative data. Although our definition of LGIB was based on prior literature, 24 this algorithm has not been validated compared with clinical chart review. However, the patient characteristics are consistent with literature based on clinically detailed data sources. The comorbid conditions and the definitions of upper gastrointestinal disease may be subject to reporting biases and/or inaccuracies. However, the rates of common comorbid conditions are consistent with estimates from the Behavioral Risk Factor Surveillance System. Also, the very strong association of a history of bleeding PUD (relative to nonbleeding) with EGD is consistent with clinical expectations. The indications for an EGD within our sample cannot be known with certainty. Furthermore, we do not have information on the physicians who cared for the patients in the sample, and our measures of physician supply and practice patterns were at the HRR level. However, numerous studies have shown that data derived from this relevant geographic unit predict utilization at the patient level among beneficiaries. 4, 6, 30 Given this and our finding that relevant clinical histories are strongly associated with decisions regarding discretionary care, we believe that this study supports the notion that links between capacity and utilization intensity may be different among commercially insured patients than among Medicare patients.
Conclusions
We show that clinical history is strongly associated with physicians' decisions to perform EGD among patients hospitalized with LGIB. There is no evidence to suggest that gastroenterologist supply or aggressive practice patterns induce demand for this procedure, which is discretionary in patients with LGIB. While policies to expand physician supply should pay careful attention to the combination of supply-side factors that may induce discretionary utilization, there is no evidence in this non-Medicare population that an increase in physician supply would produce unnecessary care. Restriction of supply could limit patient access to essential clinical services.
Dedication: We dedicate this report to our dear mentor, colleague, and friend Willard G. Manning, who passed away on November 25, 2014, after an extended illness and a struggle marked by courage, dignity, and grace. At the time of his death, Will was professor emeritus of public policy and public health sciences at the University of Chicago. He held previous faculty or senior economist positions at the University of Minnesota, the University of Michigan, the RAND Corporation, and the Kennedy School at Harvard. Will received his PhD from Stanford in 1973 and his BS from CalTech in 1968. His passion for cultivating trainees and junior faculty through kind and committed mentorship was surpassed only by his vast scholarly contributions to the field of health economics. We are grateful to have had the privilege of working with Will. He will be missed immensely.
